470 related articles for article (PubMed ID: 34025661)
1. Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls.
Olsson A; Gustavsen S; Nguyen TD; Nyman M; Langkilde AR; Hansen TH; Sellebjerg F; Oturai AB; Bach Søndergaard H
Front Immunol; 2021; 12():661493. PubMed ID: 34025661
[TBL] [Abstract][Full Text] [Related]
2. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study.
Boets E; Gomand SV; Deroover L; Preston T; Vermeulen K; De Preter V; Hamer HM; Van den Mooter G; De Vuyst L; Courtin CM; Annaert P; Delcour JA; Verbeke KA
J Physiol; 2017 Jan; 595(2):541-555. PubMed ID: 27510655
[TBL] [Abstract][Full Text] [Related]
3. The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis.
Barcutean L; Maier S; Burai-Patrascu M; Farczadi L; Balasa R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542172
[TBL] [Abstract][Full Text] [Related]
4. Associations of serum short-chain fatty acids with circulating immune cells and serum biomarkers in patients with multiple sclerosis.
Trend S; Leffler J; Jones AP; Cha L; Gorman S; Brown DA; Breit SN; Kermode AG; French MA; Ward NC; Hart PH
Sci Rep; 2021 Mar; 11(1):5244. PubMed ID: 33664396
[TBL] [Abstract][Full Text] [Related]
5. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
[TBL] [Abstract][Full Text] [Related]
6. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
7. Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis.
Zeng Q; Junli Gong ; Liu X; Chen C; Sun X; Li H; Zhou Y; Cui C; Wang Y; Yang Y; Wu A; Shu Y; Hu X; Lu Z; Zheng SG; Qiu W; Lu Y
Neurochem Int; 2019 Oct; 129():104468. PubMed ID: 31108132
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis.
Juanola O; Ferrusquía-Acosta J; García-Villalba R; Zapater P; Magaz M; Marín A; Olivas P; Baiges A; Bellot P; Turon F; Hernández-Gea V; González-Navajas JM; Tomás-Barberán FA; García-Pagán JC; Francés R
FASEB J; 2019 Oct; 33(10):11595-11605. PubMed ID: 31345057
[TBL] [Abstract][Full Text] [Related]
9. Chronotropic and vasoactive properties of the gut bacterial short-chain fatty acids in larval zebrafish.
Sree Kumar H; Wisner AS; Schiefer IT; Alviter Plata A; Zubcevic J
Physiol Genomics; 2024 Jun; 56(6):426-435. PubMed ID: 38557279
[TBL] [Abstract][Full Text] [Related]
10. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
11. The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease.
Zhong C; Dai Z; Chai L; Wu L; Li J; Guo W; Zhang J; Zhang Q; Xue C; Lin H; Luo Q; Cai K
J Clin Lab Anal; 2021 Dec; 35(12):e24062. PubMed ID: 34689373
[TBL] [Abstract][Full Text] [Related]
12. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.
Duan H; Wang L; Huangfu M; Li H
Biomed Pharmacother; 2023 Sep; 165():115276. PubMed ID: 37542852
[TBL] [Abstract][Full Text] [Related]
13. Effects of high-fiber diets enriched with carbohydrate, protein, or unsaturated fat on circulating short chain fatty acids: results from the OmniHeart randomized trial.
Mueller NT; Zhang M; Juraschek SP; Miller ER; Appel LJ
Am J Clin Nutr; 2020 Mar; 111(3):545-554. PubMed ID: 31927581
[TBL] [Abstract][Full Text] [Related]
14. Association of short-chain fatty acids and the gut microbiome with type 2 diabetes: Evidence from the Henan Rural Cohort.
Yang T; Wu C; Li Y; Wang C; Mao Z; Huo W; Li J; Li Y; Xing W; Li L
Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1619-1630. PubMed ID: 38653672
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
16. Short-chain fatty acids reprogram metabolic profiles with the induction of reactive oxygen species production in human colorectal adenocarcinoma cells.
Huang C; Deng W; Xu HZ; Zhou C; Zhang F; Chen J; Bao Q; Zhou X; Liu M; Li J; Liu C
Comput Struct Biotechnol J; 2023; 21():1606-1620. PubMed ID: 36874158
[TBL] [Abstract][Full Text] [Related]
17. Short Chain Fatty Acids Taken at Time of Thrombectomy in Acute Ischemic Stroke Patients Are Independent of Stroke Severity But Associated With Inflammatory Markers and Worse Symptoms at Discharge.
Henry N; Frank J; McLouth C; Trout AL; Morris A; Chen J; Stowe AM; Fraser JF; Pennypacker K
Front Immunol; 2021; 12():797302. PubMed ID: 35126360
[TBL] [Abstract][Full Text] [Related]
18. Short-chain fatty acids and gut microbiota in multiple sclerosis.
Melbye P; Olsson A; Hansen TH; Søndergaard HB; Bang Oturai A
Acta Neurol Scand; 2019 Mar; 139(3):208-219. PubMed ID: 30427062
[TBL] [Abstract][Full Text] [Related]
19. Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease.
Thing M; Werge MP; Kimer N; Hetland LE; Rashu EB; Nabilou P; Junker AE; Galsgaard ED; Bendtsen F; Laupsa-Borge J; McCann A; Gluud LL
BMC Gastroenterol; 2024 Jan; 24(1):43. PubMed ID: 38262952
[TBL] [Abstract][Full Text] [Related]
20. Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis.
Takewaki D; Suda W; Sato W; Takayasu L; Kumar N; Kimura K; Kaga N; Mizuno T; Miyake S; Hattori M; Yamamura T
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22402-22412. PubMed ID: 32839304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
